ArticleScience (New York, N.Y.)2024
Evolution and host-specific adaptation of
Abstract read
In one paragraph
Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.
0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed.
- Identification of DksA as a novel pro-inflammatory mediator ofVirulence · 2026Article
- On the hunt for candidate genes involved in host-adaptation in Pseudomonas aeruginosa using comparative genomics.BMC genomics · 2026Article
- How cystic fibrosis modulator therapy could transformMicrobiology (Reading, England) · 2026Review
- An extragenic fix for a broken enzyme.Microbiology (Reading, England) · 2026Article
- DNA sequencing for microbial surveillance in cystic fibrosis airways: advances, challenges, and clinical translation.Clinical microbiology reviews · 2026Review
- Enumeration Method forMicroorganisms · 2026Article
- Targeting Outer Membrane Vesicles ofJournal of microbiology and biotechnology · 2026Review
- Simulating the host niche: balancing complexity and control in the experimental evolution of antibiotic resistance and pathoadaptation.Microbiology (Reading, England) · 2026Review
- Time-Resolved Electrochemical Surface-Enhanced Resonance Raman Spectroscopy Double-Fingerprint for the Detection ofACS measurement science au · 2026Article
- Within-patient gene transfer between transiently and chronically infecting bacteria causes extreme antibiotic resistance during lung infections.Nature microbiology · 2026Article
- Article
- Beyond Resistance Genes:Life (Basel, Switzerland) · 2026Review
- Cystic fibrosis: insights from zebrafish models.Disease models & mechanisms · 2026Review
- Glycosylated graphene-nylon fiber: A new material platform to balance the nanotoxicity and bioactivity for anti-infective therapy.Bioactive materials · 2026Article
- Disrupting phage liquid crystalline droplets restores antibiotic susceptibility in Pseudomonas aeruginosa biofilms.PLoS biology · 2026Article
- Evidence of cefiderocol-persistence inBiofilm · 2026Article
- Within-patient evolution ofmSphere · 2026Article
- Carbapenem-resistance oprD mutations reshape Pseudomonas aeruginosa host-pathogen interactions during infection.Nature communications · 2026Article
- Complete genome sequences ofMicrobiology resource announcements · 2026Article
- Antibacterial and anti-virulence effects ofMicrobiology spectrum · 2026Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Aaron WeimannVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4597-2471
Adam M DinanVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-2812-1616
Christopher RuisVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0977-5534
Audrey BernutLaboratory of Pathogens and Host Immunity (LPHI), UMR5235, CNRS/Université de Montpellier, Montpellier, France.ORCID 0000-0002-1928-8329
Stéphane PontLaboratory of Pathogens and Host Immunity (LPHI), UMR5235, CNRS/Université de Montpellier, Montpellier, France.ORCID 0000-0002-8142-4133
Karen BrownVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0387-5318
Judy RyanVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Lúcia SantosDepartment of Physiology, Bioscience Institute, University College Cork, Cork, Ireland.ORCID 0000-0002-3748-3697
Louise EllisonUniversity of Cambridge Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0009-0009-2134-8034
Emem UkorUniversity of Cambridge Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0009-0003-0683-3943
Arun P PanduranganVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7168-7143
Sina KrokowskiVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Tom L BlundellVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2708-8992
Martin WelchDepartment of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0003-3646-1733
Beth BlaneDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0996-9091
Kim JudgeWellcome Sanger Institute, Hinxton, UK.
Rachel BousfieldDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7828-4048
Nicholas BrownCambridge University Hospitals Trust, Cambridge, UK.ORCID 0000-0002-6657-300X
Josephine M BryantWellcome Sanger Institute, Hinxton, UK.
Irena Kukavica-IbruljInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec City, Québec, Canada.ORCID 0009-0007-0042-8110
Giordano RampioniDepartment of Science, University Roma Tre, Rome, Italy.ORCID 0000-0002-1735-8565
Livia LeoniDepartment of Science, University Roma Tre, Rome, Italy.ORCID 0000-0002-2046-4297
Patrick T HarrisonDepartment of Physiology, Bioscience Institute, University College Cork, Cork, Ireland.ORCID 0000-0002-2319-0949
Sharon J PeacockDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1718-2782
Nicholas R ThomsonWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-4432-8505
Jeff GauthierInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec City, Québec, Canada.ORCID 0000-0002-2523-2698
Jo L FothergillDepartment of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK.ORCID 0000-0002-7012-1508
Roger C LevesqueInstitut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec City, Québec, Canada.ORCID 0000-0001-8315-5937
Julian ParkhillDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-7069-5958
R Andres FlotoVictor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2188-5659
Funding
Wellcome Trust 098051Wellcome Trust 107032Wellcome Trust 226602
Abstract
The major human bacterial pathogen
Indexed as
Cystic FibrosisPseudomonas aeruginosaPseudomonas InfectionsEvolution, MolecularGene Transfer, HorizontalHost AdaptationHost-Pathogen InteractionsHost SpecificityHumansMacrophages
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.